公司資料
PharmaCyte Biotech 股價、新聞與催化劑
- 股票代碼:
- PMCB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.56 USD (-15.08%)
收盤價
最後更新: 2026年11月19日
8.06M USD
市值
股價為何變動
截至 2026年11月19日,PMCB 下跌 15.1%,收於 $4.56。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
PharmaCyte Biotech was a biotechnology company focused on cell encapsulation and oncology before its restructuring and public-market decline. Its story centered on an experimental cancer-delivery platform.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, PharmaCyte sat in specialty biotechnology.
商業模式特徵
The business depended on clinical validation, platform feasibility, and the chance to convert a niche concept into value.
生技產業定位
PharmaCyte belongs to the historical or restructuring biotech set rather than the current live public-company universe.
未來催化劑
- PharmaCyte is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is focused on what value remains.
近期新聞
新聞標題由機器翻譯,詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。
